Abbott is delighted to announce an addition to our trusted portfolio of food for special medical purposes for infants (iFSMPs), EleCare, by Similac. EleCare is the first amino acid-based formula in the UK containing synthesised 2’-fucosyllactose (2’-FL) human milk oligosaccharide (HMO). EleCare helps support the systemic immune system, as 2’-FL HMO has proven benefits on the gut and beyond† 1, 2
Breast milk is the gold standard providing not only nutrition, but protection and support for the developing immune system,3-5 which is critical, particularly in the first year of life.6 However, not every infant with allergies can be breastfed and a number of families depend on hypoallergenic formula.
HMOs are a diverse group of bioactive, non-digestible carbohydrates and the third most abundant solid component of breast milk.7, 8 Breast milk contains many distinct HMOs, which have a positive effect on gut microbiota and play an important role systemically in supporting the developing immune system.7-10
Following 18 years of extensive research into HMOs, Abbott know that 2’-FL HMO is the most abundant HMO in most mother’s milk, and we are delighted to be the first and only medical nutrition company in the UK to add 2’-FL HMO to an amino acid-based formula.
With EleCare you can:
IMPORTANT NOTICE: Breastfeeding is best for infants and is recommended for as long as possible during infancy.
For more information, please visit: https://nutrition.abbott/uk/product/elecare
References: 1. Reverri EJ, et al. Nutrients. 2018;10(10). pii: E1346. 2. Marriage BJ, et al. J Pediatr Gastroenterol Nutr. 2015;61(6):649–658. 3.Kainonen E, et al. Immunological programming by breast milk creates an anti-inflammatory cytokine milieu in breast-fed infants compared to formula-fed infants. Brit J Nutrition 2013;109(11):1962–1970. 4. Walker A. Breast milk as the gold standard for protective nutrients. J Pediatr 2010;156(Suppl 2):S3–S7. 5. Lessen R, Kavanagh K. Position of the academy of nutrition and dietetics: promoting and supporting breastfeeding. J Acad Nutr Diet 2015;115(3):444–449. 6. Simon AK, et al. Proc Biol Sci 2015;282(1821): 20143085. 7. Triantis V, et al. Immunological Effects of Human Milk Oligosaccharides. Front Pediatr 2018;6:190. 8. Castanys-Munoz E, et al. Building a Beneficial Microbiome from Birth. Adv Nutr 2016;7(2):323–330. 9. Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology 2012;22(9):1147–1162. 10. Stepans MB, et al. Early consumption of human milk oligosaccharides is inversely related to subsequent risk of respiratory and enteric disease in infants. Breastfeed Med 2006;1(4):207–215. 11. Goehring KC, et al. J Nutr. 2016;146(12):2559–2566. 12. Sicherer SH, et al. J Pediatr. 2001;138:688 -693. 13. Borschel MW, et al. Clin Pediatr (Phila). 2013;52(10):910–917. 14. Borschel MW, et al. BMC Pediatr. 2014;14:136. 15. RTI research. Abbott Elecare No.1 Dr Recommended. Final Results. 2019. [PowerPoint presentation]. 16. Abbott. EleCare Promotional Claims Parent Survey. 2019
†Data collected from healthy-term infants fed standard infant formula (Similac) with 2’-FL HMO, compared to control formula without
‡Data collected from infants fed standard EleCare formula without 2’-FL HMO.
Date of preparation: February | ANUKANI200054